Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series

ABSTRACT The present study reports several case studies about the use of androgenic-anabolic steroids (AAS) by patients under treatment for substance use disorder (SUD). Ten subjects were interviewed, two women and eight men, ranging from 25 to 43 years old. Regarding treatment regime, eight subjects were inpatients and two, outpatients. ASSIST-WHO and MINI-SUD scales and a semi-structured interview were used as research instruments. Seven subjects reported the use of AAS within fewer than twelve months from the interview date. Mental health professionals did not previously question none of the subjects were about the use of AAS. We discuss the efficacy of the chosen instruments to assess AAS use.

Saved in:
Bibliographic Details
Main Authors: Amaral,Julio Mario Xerfan do, Cruz,Marcelo Santos
Format: Digital revista
Language:English
Published: Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852017000200120
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0047-20852017000200120
record_format ojs
spelling oai:scielo:S0047-208520170002001202017-07-28Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case seriesAmaral,Julio Mario Xerfan doCruz,Marcelo Santos Anabolic agents steroids substance-related disorders. ABSTRACT The present study reports several case studies about the use of androgenic-anabolic steroids (AAS) by patients under treatment for substance use disorder (SUD). Ten subjects were interviewed, two women and eight men, ranging from 25 to 43 years old. Regarding treatment regime, eight subjects were inpatients and two, outpatients. ASSIST-WHO and MINI-SUD scales and a semi-structured interview were used as research instruments. Seven subjects reported the use of AAS within fewer than twelve months from the interview date. Mental health professionals did not previously question none of the subjects were about the use of AAS. We discuss the efficacy of the chosen instruments to assess AAS use.info:eu-repo/semantics/openAccessInstituto de Psiquiatria da Universidade Federal do Rio de JaneiroJornal Brasileiro de Psiquiatria v.66 n.2 20172017-06-01info:eu-repo/semantics/reporttext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852017000200120en10.1590/0047-2085000000160
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Amaral,Julio Mario Xerfan do
Cruz,Marcelo Santos
spellingShingle Amaral,Julio Mario Xerfan do
Cruz,Marcelo Santos
Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
author_facet Amaral,Julio Mario Xerfan do
Cruz,Marcelo Santos
author_sort Amaral,Julio Mario Xerfan do
title Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
title_short Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
title_full Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
title_fullStr Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
title_full_unstemmed Use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
title_sort use of androgenic anabolic steroids by patients under treatment for substance use disorder: case series
description ABSTRACT The present study reports several case studies about the use of androgenic-anabolic steroids (AAS) by patients under treatment for substance use disorder (SUD). Ten subjects were interviewed, two women and eight men, ranging from 25 to 43 years old. Regarding treatment regime, eight subjects were inpatients and two, outpatients. ASSIST-WHO and MINI-SUD scales and a semi-structured interview were used as research instruments. Seven subjects reported the use of AAS within fewer than twelve months from the interview date. Mental health professionals did not previously question none of the subjects were about the use of AAS. We discuss the efficacy of the chosen instruments to assess AAS use.
publisher Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852017000200120
work_keys_str_mv AT amaraljuliomarioxerfando useofandrogenicanabolicsteroidsbypatientsundertreatmentforsubstanceusedisordercaseseries
AT cruzmarcelosantos useofandrogenicanabolicsteroidsbypatientsundertreatmentforsubstanceusedisordercaseseries
_version_ 1756381326072610816